Home

IONIS PHARMACEUTICALS INC

CIK 874015 · last filed 2020-10-14

IONIS PHARMACEUTICALS INC is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2012. Across all open-market trades the lifetime net is +$222.5M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

13

Lifetime Open-Market Net

$222.50M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKCEA THERAPEUTICS, INC. (AKCA) Delisted 10%+ Owner 77,094,682 — — $225.00M 6 2019-12-19
Regulus Therapeutics Inc. (RGLS) Delisted Director 5,451,172 $8.16 $44.48M -$2.50M 6 2015-07-17

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-14 — Buy (P) +21,237,715 $385.46M
2019-12-19 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Other (J) +6,873,344 $0 EDGAR
2019-04-02 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Other (J) +2,837,373 $0 EDGAR
2018-10-18 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Other (J) +1,671,849 $0 EDGAR
2018-08-06 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Other (J) +1,597,571 $0 EDGAR
2018-04-19 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Mixed +18,666,666 $200.00M EDGAR
2017-07-21 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Mixed +45,447,879 $25.00M EDGAR
2015-07-17 Regulus Therapeutics Inc. (RGLS) Delisted Sell (S) −343,133 -$3.64M EDGAR
2015-07-02 Regulus Therapeutics Inc. (RGLS) Delisted Mixed — -$143.0K EDGAR
2014-10-28 Regulus Therapeutics Inc. (RGLS) Delisted Sell (S) −113,084 -$1.59M EDGAR
Showing 1–10 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.